Breast Cancer Misdiagnosis Costs U.S. $4B Every Year: Study

  • Written by: Irvin Jackson
  • 1 Comment

New research suggests that billions are spent each year on unnecessary health costs associated with misread mammograms, which result in breast cancer misdiagnosis and over-treatment of tumors that do not actually pose a threat.

In a study published in the April issue of the medical journal Health Affairs, researchers from Harvard Medical School and Boston Children’s Hospital looked at the cost of false-positive mammography findings and the overdiagnosis of breast cancer. The findings suggest that, combined, the issues cost the U.S. $4 billion annually among women between the ages of 40 and 59.

Researchers looked at expenditure data from a major U.S. health care insurance company involving more than 700,000 women between 2011 to 2013. They found that the costs associated with false-positive mammogram, invasive breast cancer, and ductal carcinoma in situ were much higher than previously believed.

Treating breast cancer costs $51,837 on average per case, and ductal carcinoma cases cost $12,369. Researchers estimate that about 22% of breast cancer cases were misdiagnosis or over treatment. They determined that 86% of ductal carcinoma cases were misdiagnoses.

Mammograms cost $852 each, but were much more common. The researchers estimate that about 11% of those are false-positives, meaning they indicated a women had cancer when she did not. In fact, mammogram cancer misdiagnosis costs the U.S. $2.8 billion each year.

Breast cancer overdiagnosis, where tumors are believed to be more of a problem than they actually are, resulting in overtreatment, costs $1.2 billion per year.

The study comes amid debate over when and how often women should get screened for breast cancer, which kills nearly 41,000 U.S. women every year. Previously, mammograms were recommended for all women starting at 40 years of age, but recently that has been heavily debated.

These findings, which resulted in a much higher cost for breast cancer misdiagnosis than anticipated, is likely to add to the ongoing debate.

“The costs associated with false-positive mammograms and breast cancer overdiagnoses appear to be much higher than previously documented,” the researchers concluded. “Screening has the potential to save lives. However, the economic impact of false-positive mammography results and breast cancer overdiagnoses must be considered in the debate about the appropriate populations for screening.”

Officials from the American Cancer Society are already pushing back against the study’s findings, saying that it does not factor in all the lives saved by screening and early detection, which probably save the U.S. healthcare system a significant amount of money by avoiding chemotherapy and other expensive treatments and drugs for advanced stage breast cancer.

Tags: , ,

1 comment

  1. Darren Reply

    One of the “officials of the American Cancer Society,” a pawn group and member of the orthodox medical business, by the name of Wender, had commented on this study stating that “I strongly feel that every study that looks at the downsides of any screening test has to be balanced with the benefits” yet the American Cancer Society has been a crucial force to get mass mammography introduced by consistently downplaying and disregarding the known serious risks of the procedure while the group had consistently overstated its benefits. It’s hypocrisy at its best, it’s corruption at its best.

    The real research data also shows hat the more mammography screening the more invasive cancer treatments are getting performed, opposing the hype put out by the cancer industry (American Cancer Society, pink ribbon groups, radiologists/oncologists, etc).

    Mammograms are linked to all kinds of severe harms, including significant overdiagnosis and increased total mortality. The two most thorough, extensive, and reliable accounts of the non-science of mammography, the large body of relevant anti-mammogram evidence that’s been ignored by the mammogram industry, and the huge influence of big money and politics on the dominant status of mass screening read “Mammography Screening: Truth, Lies and Controversy” by Peter Gotzsche and “The Mammogram Myth” by Rolf Hefti – more at TheMammogramMyth dot com

    IF women (and men) at large were to scrutinize the mammogram data above and beyond the information of the mammogram industry (eg American Cancer Society, National Cancer Institute, Komen), they’d also find that it is almost exclusively the big profiteers of the test (eg radiologists, oncologists, medical trade associations, breast cancer “charities” etc) who promote the mass use of the test and that most pro-mammogram “research” is conducted by people with massive vested interests tied to the mammogram industry.

  • Share Your Comments

  • Have Your Comments Reviewed by a Lawyer

    Provide additional contact information if you want an attorney to review your comments and contact you about a potential case. This information will not be published.
  • NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

  • This field is for validation purposes and should be left unchanged.